GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » Cash Flow from Investing

Shanghai Medicilon (SHSE:688202) Cash Flow from Investing : ¥-106 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2025, Shanghai Medicilon spent ¥18 Mil on purchasing property, plant, equipment. It gained ¥0 Mil from selling property, plant, and equipment. It spent ¥0 Mil on purchasing business. It gained ¥0 Mil from selling business. It spent ¥215 Mil on purchasing investments. It gained ¥159 Mil from selling investments. It paid ¥0Mil for net Intangibles purchase and sale. And it received ¥0 Mil from other investing activities. In all, Shanghai Medicilon spent ¥75 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2025.


Shanghai Medicilon Cash Flow from Investing Historical Data

The historical data trend for Shanghai Medicilon's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon Cash Flow from Investing Chart

Shanghai Medicilon Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -371.60 -399.55 -311.62 -787.55 -89.97

Shanghai Medicilon Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.43 62.87 80.99 -175.41 -74.51

Shanghai Medicilon Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Shanghai Medicilon's Cash Flow from Investing for the fiscal year that ended in Dec. 2024 is calculated as:

Shanghai Medicilon's Cash Flow from Investing for the quarter that ended in Mar. 2025 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-106 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon  (SHSE:688202) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Shanghai Medicilon's purchase of property, plant, equipment for the three months ended in Mar. 2025 was ¥-18 Mil. It means Shanghai Medicilon spent ¥18 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Shanghai Medicilon's sale of property, plant, equipment for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Medicilon gained ¥0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Shanghai Medicilon's purchase of business for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Medicilon spent ¥0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Shanghai Medicilon's sale of business for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Medicilon gained ¥0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Shanghai Medicilon's purchase of investment for the three months ended in Mar. 2025 was ¥-215 Mil. It means Shanghai Medicilon spent {stock_data.stock.currency_symbol}}215 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Shanghai Medicilon's sale of investment for the three months ended in Mar. 2025 was ¥159 Mil. It means Shanghai Medicilon gained ¥159 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Shanghai Medicilon's net Intangibles purchase and sale for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Medicilon paid ¥0 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Shanghai Medicilon's cash from discontinued investing activities for the three months ended in Mar. 2025 was 0 Mil. It means Shanghai Medicilon paid ¥0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Shanghai Medicilon's cash from other investing activities for the three months ended in Mar. 2025 was ¥0 Mil. It means Shanghai Medicilon received ¥0 Mil from other investing activities.


Shanghai Medicilon Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Medicilon Business Description

Traded in Other Exchanges
N/A
Address
Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Executives
Chen Jin Zhang Director
Chen Guo Xing Director
Lin Zhang Qing Director
Peng Shuang Qing Core technical personnel
Li Zhi Gang Core technical personnel
Xu Yong Mei Core technical personnel
Liu Bin Bin senior management
Zhang Xiao Dong senior management
Xue Chao senior management
Ma Xing Quan senior management
Directors, senior managers, core technical personn
Cai Jin Na Directors, senior managers

Shanghai Medicilon Headlines

No Headlines